Development and Evaluation of Novel Drug Delivery Systems for Targeted Cancer Therapy

Thesis Abstract

Abstract
The treatment of cancer poses a significant challenge due to the complexity and heterogeneity of the disease. Conventional chemotherapy often lacks specificity, leading to off-target effects and limited efficacy. In recent years, the development of novel drug delivery systems has emerged as a promising approach to enhance the effectiveness of cancer therapy while minimizing systemic toxicity. This thesis focuses on the development and evaluation of novel drug delivery systems for targeted cancer therapy, with a specific emphasis on addressing the limitations of current treatment modalities. Chapter 1 provides an introduction to the background of the study, outlining the problem statement, objectives, limitations, scope, significance, structure of the thesis, and definition of key terms. The chapter sets the stage for the research by highlighting the need for more targeted and effective drug delivery systems in cancer therapy. Chapter 2 presents a comprehensive literature review, which critically evaluates existing research on drug delivery systems for cancer therapy. The review covers ten key areas, including the challenges of current cancer treatment modalities, the importance of targeted drug delivery, various types of drug delivery systems, and recent advancements in the field. Chapter 3 details the research methodology employed in this study. The chapter includes discussions on the selection of drug delivery systems, formulation development, in vitro and in vivo testing methodologies, data analysis techniques, and ethical considerations. The methodology section provides a clear and systematic approach to the experimental design and evaluation of novel drug delivery systems. Chapter 4 presents a detailed discussion of the findings obtained from the experimental evaluation of the developed drug delivery systems. The chapter includes analyses of the physicochemical properties, drug release profiles, cellular uptake mechanisms, cytotoxicity studies, and in vivo efficacy of the novel drug delivery systems. The results highlight the potential of the developed systems to improve the targeted delivery of anticancer agents and enhance therapeutic outcomes. Chapter 5 concludes the thesis by summarizing the key findings, discussing their implications for targeted cancer therapy, and suggesting future research directions. The chapter emphasizes the significance of the developed drug delivery systems in overcoming the challenges associated with conventional cancer treatment modalities and improving patient outcomes. In conclusion, this thesis contributes to the field of cancer therapy by providing insights into the development and evaluation of novel drug delivery systems for targeted treatment. The research findings underscore the potential of these systems to revolutionize cancer therapy by enhancing drug delivery efficiency, reducing systemic toxicity, and improving patient outcomes.